A pharmaco-kinetic study on TS-1+CDDP+PTXtreatment for advanced and/or metastatic gastric cancer (OGSG 0703 plus)
- Conditions
- advanced and/or metastatic gastric cancer
- Registration Number
- JPRN-UMIN000002951
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Not provided
1. with fresh bleeding from digestive tract 2. without ability of oral intake due to digestive tract obstruction 3. with history of severe allergy against medicine, especially, Medicines including Polyethylene-caster oil 4. with ascites and/or pleural fluid 5. with severe diseases (infectious diseases, interstitial pneumonia, Pulmonary fibrosis, cardiac dysfunction, renal dysfunction, liver dysfunction, uncontrolled DM etc) 6. with liver cirrhosis and/or jaundice 7. under treatment using psychotrophic agents or with a disease which needs psychological treatment 8. with some symptoms due to brain metastasis 9. with active double cancer 10. pregnant or nursing lady or lady with expectation of pregnancy 11. Any other patient whom the physician in charge of the study judges to be not eligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method